Transcat, Inc. (NASDAQ:TRNS) Holdings Decreased by BNP Paribas Financial Markets

BNP Paribas Financial Markets trimmed its stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 68.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,078 shares of the scientific and technical instruments company's stock after selling 15,583 shares during the quarter. BNP Paribas Financial Markets owned 0.08% of Transcat worth $748,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of TRNS. Ameriprise Financial Inc. raised its position in shares of Transcat by 2.6% during the 4th quarter. Ameriprise Financial Inc. now owns 70,997 shares of the scientific and technical instruments company's stock worth $7,507,000 after acquiring an additional 1,804 shares in the last quarter. Comerica Bank increased its stake in Transcat by 5.9% in the fourth quarter. Comerica Bank now owns 64,600 shares of the scientific and technical instruments company's stock valued at $6,831,000 after purchasing an additional 3,594 shares during the last quarter. Northern Trust Corp raised its holdings in Transcat by 6.7% during the fourth quarter. Northern Trust Corp now owns 114,755 shares of the scientific and technical instruments company's stock worth $12,134,000 after purchasing an additional 7,171 shares in the last quarter. Aquatic Capital Management LLC raised its holdings in Transcat by 1,052.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,052 shares in the last quarter. Finally, Nebula Research & Development LLC lifted its position in shares of Transcat by 31.6% during the 4th quarter. Nebula Research & Development LLC now owns 7,103 shares of the scientific and technical instruments company's stock worth $751,000 after buying an additional 1,707 shares during the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Stock Down 0.7%

NASDAQ TRNS traded down $0.63 during mid-day trading on Wednesday, reaching $91.41. 3,833 shares of the company's stock traded hands, compared to its average volume of 81,826. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The company has a fifty day simple moving average of $80.28 and a 200-day simple moving average of $89.38. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $147.12. The company has a market cap of $850.94 million, a price-to-earnings ratio of 49.22 and a beta of 0.69.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). The business had revenue of $77.13 million for the quarter, compared to the consensus estimate of $76.40 million. Transcat had a net margin of 6.22% and a return on equity of 7.23%. The firm's quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities research analysts expect that Transcat, Inc. will post 2.3 EPS for the current year.

Analyst Upgrades and Downgrades

TRNS has been the topic of several research analyst reports. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Northland Securities reaffirmed a "market perform" rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. HC Wainwright reissued a "buy" rating and set a $116.00 target price (up from $106.00) on shares of Transcat in a research note on Wednesday, May 21st. Finally, Wall Street Zen raised Transcat from a "sell" rating to a "hold" rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.